RE: long-acting injectables16 Feb 2021 10:38
After MedinCell has launched a COVID-19 research initiative based on its experience
to formulate long-acting injectable Ivermectin
they raised € 10,900,000 in May & € 15,600,000 in June and last raised was € 30,000,000 on Feb 2021
We all know that Midatech has changed with a new approach
{ partnering / licencing / milstone payments............ }